> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# OMB Approves 9 Information Collections
- URL: https://www.fdaweb.com/omb-approves-9-information-collections/
- Published: 2019-04-15T12:00:00.000Z
- Updated: 2026-09-15T01:20:24.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5143864

*Federal Register* notice: FDA is publishing a list of nine information collections that have been approved by OMB. They are:

- Registration of Producers of Drugs and Listing of Drugs in Commercial Distribution
- Biosimilar User Fee Program
- Surveys and Interviews with Investigational New Drug Sponsors to Assess Current Communication Practices with FDA Review Staff Under the Sixth Authorization of the Prescription Drug User Fee Act
- Disclosures of Descriptive Presentations in Professional Oncology Prescription Drug Promotion
- Requirements on Content and Format of Labeling for Human Prescription Drug and Biological Products
- General Licensing Provisions; Section 351(k) Biosimilar Applications
- Labeling of Certain Beers Subject to the Labeling Jurisdiction of the FDA
- Implementation of the Drug Supply Chain Security Act -Identification of Suspect Product and Notification
- Reclassification Petitions for Medical Devices

To view the notice, click [here](https://s3.amazonaws.com/public-inspection.federalregister.gov/2019-07467.pdf?ref=fdaweb.com).